Literature DB >> 16338658

The hypoxic microenvironment of the skin contributes to Akt-mediated melanocyte transformation.

Barbara Bedogni1, Scott M Welford, David S Cassarino, Brian J Nickoloff, Amato J Giaccia, Marianne Broome Powell.   

Abstract

Constitutive activation of Akt characterizes a high percentage of human melanomas and represents a poor prognostic factor of the disease. We show that Akt transforms melanocytes only in a hypoxic environment, which is found in normal skin. The synergy between Akt and hypoxia is HIF1alpha mediated. Inhibition of HIF1alpha decreases Akt transformation capacity in hypoxia and tumor growth in vivo, while overexpression of HIF1alpha allows anchorage-independent growth in normoxia and development of more aggressive tumors. Finally, we show that mTOR activity is necessary to maintain the transformed phenotype by sustaining HIF1alpha activity. Taken together, these findings demonstrate that Akt hyperactivation and HIF1alpha induction by normally occurring hypoxia in the skin significantly contribute to melanoma development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16338658     DOI: 10.1016/j.ccr.2005.11.005

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  66 in total

1.  Regulation of the ring finger E3 ligase Siah2 by p38 MAPK.

Authors:  Ashwani Khurana; Koh Nakayama; Scott Williams; Roger J Davis; Tomas Mustelin; Ze'ev Ronai
Journal:  J Biol Chem       Date:  2006-09-25       Impact factor: 5.157

2.  Akt blocks the tumor suppressor activity of LKB1 by promoting phosphorylation-dependent nuclear retention through 14-3-3 proteins.

Authors:  Ling Liu; Fung-Ming Siu; Chi-Ming Che; Aimin Xu; Yu Wang
Journal:  Am J Transl Res       Date:  2012-04-10       Impact factor: 4.060

3.  Knockdown of FBXO22 inhibits melanoma cell migration, invasion and angiogenesis via the HIF-1α/VEGF pathway.

Authors:  Yufan Zheng; Hairong Chen; Yang Zhao; Xuping Zhang; Jinjin Liu; Yu Pan; Jin Bai; Hongwei Zhang
Journal:  Invest New Drugs       Date:  2019-03-18       Impact factor: 3.850

4.  A gene expression signature of invasive potential in metastatic melanoma cells.

Authors:  Aaron R Jeffs; Amy C Glover; Lynn J Slobbe; Li Wang; Shujie He; Jody A Hazlett; Anshul Awasthi; Adele G Woolley; Elaine S Marshall; Wayne R Joseph; Cristin G Print; Bruce C Baguley; Michael R Eccles
Journal:  PLoS One       Date:  2009-12-24       Impact factor: 3.240

5.  Hypoxia suppression of Bim and Bmf blocks anoikis and luminal clearing during mammary morphogenesis.

Authors:  Kelly A Whelan; Sarah A Caldwell; Kristina S Shahriari; S RaElle Jackson; Lisa D Franchetti; Gregg J Johannes; Mauricio J Reginato
Journal:  Mol Biol Cell       Date:  2010-09-22       Impact factor: 4.138

6.  Nutrient withdrawal rescues growth factor-deprived cells from mTOR-dependent damage.

Authors:  Emiliano Panieri; Gabriele Toietta; Marina Mele; Valentina Labate; Sofia Chiatamone Ranieri; Salvatore Fusco; Valentina Tesori; Annalisa Antonini; Giuseppe Maulucci; Marco De Spirito; Tommaso Galeotti; Giovambattista Pani
Journal:  Aging (Albany NY)       Date:  2010-08       Impact factor: 5.682

7.  Endothelin-1 inhibits prolyl hydroxylase domain 2 to activate hypoxia-inducible factor-1alpha in melanoma cells.

Authors:  Francesca Spinella; Laura Rosanò; Martina Del Duca; Valeriana Di Castro; Maria Rita Nicotra; Pier Giorgio Natali; Anna Bagnato
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

8.  Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc/HIF-1alpha/Sp4.

Authors:  Wen-Bin Tsai; Isamu Aiba; Soo-yong Lee; Lynn Feun; Niramol Savaraj; Macus Tien Kuo
Journal:  Mol Cancer Ther       Date:  2009-12       Impact factor: 6.261

9.  Breast carcinoma cells in primary tumors and effusions have different gene array profiles.

Authors:  Sophya Konstantinovsky; Yoav Smith; Sofia Zilber; Helene Tuft Stavnes; Anne-Marie Becker; Jahn M Nesland; Reuven Reich; Ben Davidson
Journal:  J Oncol       Date:  2009-08-11       Impact factor: 4.375

Review 10.  Tumour vascularization: sprouting angiogenesis and beyond.

Authors:  Femke Hillen; Arjan W Griffioen
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.